Dian Diagnostics released its 2026 interim report, with net profit attributable to the parent company of 232 million yuan, up 2160.87% from the same period last year. Total operating revenue was 4.773 billion yuan, down 3.30% year-on-year. Net cash inflow from operating activities was 259 million yuan, down 6.59% year-on-year. The latest asset-liability ratio was 37.97%, down 5.04 percentage points from the same period last year. Gross margin was 30.12%, rising for two consecutive quarters. Diluted earnings per share were 0.38 yuan, up 2163.10% year-on-year.
Zhejiang DiAn Diagnostics CoNet profit surged 2160.87% year-on-year, with gross margin rising for two consecutive quarters.